Panel Session: Navigating Supplier Diversification to Reduce Risk & Maintain Product Continuity

• Addressing challenges in qualifying secondary suppliers for critical materials
• Understanding comparability and change control requirements when switching vendors
• Balancing supply chain flexibility with IP constraints

Speakers:

Lili Belcastro

Associate Director, Raw Materials, Drug Product Process Development

Bristol Myers Squibb

Shawn Wang

Director, Head of Material Development

Kite Pharma